Insight Molecular Diagnostics Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Gross Margin | — | — | — | — | — |
| Operating Expenses | |||||
| Research & Development | $6.5M | $7.2M | $5.7M | $4.5M | $4.0M |
| SG&A Expense | $7.0M | $9.2M | $4.3M | $3.9M | $1.0M |
| Operating Income | $-15.2M | $-18.8M | $-11.1M | $-8.7M | $-5.0M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | — | — | $0 | $18.0K | $0 |
| Pretax Income | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — |
| Net Income | $-15.8M | $-19.4M | $-11.2M | $-8.7M | $-5.0M |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | $0.00 | $-0.01 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $-0.01 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 5.04B | 3.90B | 3.56B | 3.15B | — |
| Shares Outstanding (Diluted) | 5.04B | 3.90B | 3.56B | 3.15B | — |
| Dividends Per Share | — | — | — | — | — |